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Human embryonic stem cell (hESC)-derived midbrain dopamine (DA) neurons
stand out as a cell source for transplantation with their sustainability and con-
sistency superior to the formerly used fetal tissues. However, multiple studies
of DA neurons in culture failed to register action potential (AP) generation
upon synaptic input. To test whether this is due to deficiency of NMDA recep-
tor (NMDAR) coagonists released from astroglia, we studied the functional
properties of neural receptors in hESC-derived DA neuronal cultures. We find
that, apart from an insufficient amount of coagonists, lack of interneuronal
crosstalk is caused by hypofunction of synaptic NMDARs due to their direct
inhibition by synaptically released DA. This inhibitory tone is independent of
DA receptors and affects the NMDAR coagonist binding site.
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Morphological studies provide the most detailed
description of human neural development, outlining
a multicomponent process of neurogenesis, where
early neuroepithelial cells form neural networks and
major CNS elements [1]. These studies, however, do
not answer the question of how a naїve stem cell
becomes a functionally mature neuron, since they do
not monitor electrophysiological properties, which
are critical for neuronal function, at the cellular and
molecular level. In contrast, observations of human
embryonic stem cells (hESCs), capable of differentia-
tion into the majority of known cell types [2,3],
allow systematic evaluation of a neuron’s functional
development under highly reproducible conditions,
since hESCs can be patterned into region- and func-
tion-specific cells [4,5], in particular into dopamine
(DA) neurons [6,7]. Of note is that the early stages
of hESC-derived neuronal differentiation correspond
to the early developmental stages of corresponding
neuron types in the prenatal and neonatal brain [8].
In accordance with these observations, hESC-derived
DA neurons in culture display slow functional devel-
opment when compared to other neural cell types
[7], as was revealed by the slowly developing electro-
physiological properties of DA neurons in the native
midbrain [9].
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Parkinson’s disease (PD) is a neurodegenerative dis-
order, which affects ~ 1% of the human population
over 60 years old. Currently, cell replacement therapy
provides a promising approach for PD treatment, as
its physiological restoration of the dopaminergic sys-
tem alleviates motor symptoms and can result in a
reduced dependency on levodopa medication [10].
Such rebuilding of the dopaminergic network is not
possible by popular treatments such as deep brain
stimulation [11]. Fetal midbrain tissues were formerly
used for such cell replacement therapy with variable
results [12–14], but are now being replaced by more
consistent and sustainable cell sources such as mid-
brain DA progenitors derived from hESCs or human-
induced pluripotent stem cells (hiPSCs). The hESC/
hiPSC-derived midbrain DA progenitors matured into
midbrain DA neurons in vivo after transplantation and
were comparably potent and efficient in rescuing ani-
mal PD models as fetal midbrain tissues [15,16]. The
first patients with hiPSC-derived grafts have been
transplanted [17] with more clinical trials in prepara-
tion [18,19]. The key requirement for transplantable
cells is indeed the ability to interconnect with host neu-
ral tissue and thus establish the controlled DA release
needed for restoration of normal CNS functioning.
Electrophysiological characterization of hESC-
derived neurons is a common element performed in
the course of development of a vast majority of differ-
entiation protocols [6,20,21]. Electrophysiological stud-
ies of hESC-derived neurons have revealed a wide
range of molecular actors supporting interneuronal sig-
nalling: first, receptors of main excitatory and inhibi-
tory neurotransmitters: AMPA receptors (AMPARs)
[22–24], NMDA receptors (NMDARs) [23,25],
GABAA receptors (GABAARs) [22,26], glycine recep-
tors (GlyRs) [26], acetylcholine receptors [22], etc; and
second, functional voltage-gated sodium, potassium
and calcium channels [25,27,28]. This was supported
by the observation of functional GABAB receptors in
mouse ESCs [29], thus suggesting the full set of molec-
ular elements needed for neural signalling to be pre-
sent. Next, hESC-derived neurons were repeatedly
shown to generate single [30,31] and/or multiple [32,33]
action potentials (APs), both upon current injection
and spontaneously [34]. In addition, spontaneous and
evoked inhibitory postsynaptic currents (IPSCs) and
excitatory postsynaptic currents (EPSCs) were found
in neural networks composed from hESC-derived neu-
rons, thus revealing the presence of fully functional
synapses [35].
Being a subset of hESC-derived neurons, DA neu-
rons possess the main subtypes of functional inhibitory
(GABAARs, GlyRs) [36,37] and excitatory (AMPARs,
NMDARs) [27] receptors, whereas gaining of full
receptors’ functionality accompanies the cell differenti-
ation and maturation [27]. Together with observations
of GABA/DA corelease [38] and glutamate/DA core-
lease [39,40], this suggests normal synaptic signalling
to be present between pairs of DA neurons. Neverthe-
less, to the best of our knowledge, to date there are no
data confirming interneuronal synaptic crosstalk evok-
ing APs firing in cultured hESC-derived DA neural
networks. This is in line with our pilot experiments,
where we failed to generate network-delivered AP (s)
with the same experimental protocol [41] as had suc-
cessfully been used previously to evoke I/EPSCs by
extracellular stimulation in non-DA hESC-derived
neural cultures [35] (Fig. 2C).
Our pilot results thus reproduce an earlier study,
where hESC-derived DA neurons did generate APs
upon current injection, but not in response to extracel-
lular stimulation [42]. Notably, after 49 days in vitro
(DIV) hESC-derived non-DA neurons were shown to
generate evoked postsynaptic potentials (EPSPs) exclu-
sively with AMPARs, but without any detectable
NMDAR input. This was interpreted as a sign of
immature synapses [43].
Hence, in this study we set out to clarify the limiting
factor(s) preventing interneuronal crosstalk and gener-
ation of APs in response to synaptic input in a net-
work of hESC-derived DA neurons. Taking into
account data on slow maturation of DA neurons [7,9]
and possible low NMDAR functionality in hESC-
derived neural cells [43], we decided to investigate
these factors foremost.
Materials and methods
Generation of DA neurons
Dopamine neurons were differentiated from hESCs (RC17,
passage 27) as previously described [44]. Briefly, hESCs
were self-renewed in StemMACS iPS-Brew XF (Miltenyi
Biotec, Bisley, UK) on Laminin-521 (Biolamina, Stock-
holm, Sweden) and mycoplasma tested with negative result.
Whole-genome single nucleotide polymorphism array anal-
ysis did not reveal any copy-number variations other than
what was previously reported [45]. On differentiation day
0, hESCs were seeded at 40 000 cells per cm2 onto Lami-
nin-111 (Biolamina)-coated 24-well plates (Corning, Corn-
ing, NY, USA) according to adaption from a published
floor plate protocol for midbrain DA differentiation [46].
From day 0 to 4, cells were differentiated in neural
induction medium (NIM), which is 50% Dulbecco’s Modi-
fied Eagle’s medium/F12 (Thermo Fisher Scientific, Wal-
tem, MA, USA) + 50% Neurobasal media (Thermo Fisher
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Scientific) + B27 supplement (without vitamin A, 1 : 50;
Thermo Fisher Scientific) + N2 supplement (1 : 100;
Thermo Fisher Scientific) + L-glutamine (2 mM; Thermo
Fisher Scientific). From day 4 to 11, cells were differenti-
ated in neural patterning medium (NPM), the component
of which was similar to NIM apart from the concentration
of B27 and N2 supplement that was half of NIM. From
day 11, cells were differentiated in neural differentiation
medium (NDM), which was Neurobasal Media + B27 sup-
plement (1 : 50) + L-glutamine (2 mM).
From day 0 to 9, SB431542 (SB, 10 μM; Millipore,
Burlington, MA, USA), LDN-193189 (LDN, 100 ngmL−1;
Miltenyi Biotec), Shh-C24II (SHH, 600 ngmL−1; R&D
Systems) and CHIR99021 (CHIR, 1.0 μM; Miltenyi Biotec)
were added in NIM or NPM and medium was changed on
day 2, 4 and 7. From day 9 to 11, FGF8b (100 ngmL−1;
R&D Systems, Minneapolis, MN, USA) and heparin
(1 μgmL−1; Sigma, Dorset, UK) were added to NPM. On
day 11, cells were lifted with Accutase (Sigma) and replated
onto Laminin-111-coated 24-well plates at 800 000 cells per
cm2. From day 11 to 16, FGF8b, heparin, ascorbic acid
(AA, 0.2 mM; Sigma), brain-derived neurotrophic factor
(BDNF, 20 ngmL−1; Peprotech, Neuilly-Sur-Seine, France)
and glial cell line-derived neurotrophic factor (GDNF,
10 ngmL−1; Peprotech) were added to NDM. Cells were
fed on day 14 and lifted with Accutase on day 16 followed
by replating onto Laminin-111-coated 24-well plates at
800 000 cells per cm2. From day 16, cells were fed every 2–
3 days with NDM supplemented with BDNF, GDNF, AA,
dibutyryl cyclic AMP 0.5 mM, (Sigma) and DAPT (1 μM;
Tocris, Bristol, UK). On 23 DIV, cells were lifted with
Accutase, replated onto polyornithine (0.0015%; Sigma) +
Laminin-111-coated plates at 15 000 or 25 000 cells per
cm2 on coverslips (VWR) for electrophysiology, at 25 000
cells per cm2 on 8-well glass bottom plates (Ibidi) for
immunostaining, or at 80 000 cells per cm2 on 24-well
plates for HPLC. After day 23 replating, feeding frequency
was reduced to weekly with half media change. From day
45, DAPT was omitted from the feeding medium. A step-
by-step version of this protocol is available at: https://doi.
org/10.17504/protocols.io.bddpi25n.
Immunostaining and image analysis
Cells were fixed with 4% PFA and blocked with 2% don-
key serum (Sigma) or 2% goat serum (Sigma) in PBS-T
[0.1% Triton X-100 (Fisher) in PBS (Thermo Fisher Scien-
tific)]. Primary antibodies used are LMX1A (1 : 1000; Mil-
lipore), FOXA2 (1 : 100; Santa Cruz, Dallas, TX, USA),
tyrosine hydroxylase (TH) (1 : 1000; Millipore), β-III tubu-
lin (1 : 1000; Abcam, Cambridge, UK), synapsin (1 : 1000;
Millipore), PSD95 (1 : 250; Biolegend, San Diego, CA,
USA), PSD95 (1 : 1000; Thermo Fisher Scientific),
NMDAR2A/B (1 : 200; Merck, Darmstadt, Germany),
GABAARα1 (1 : 1000; Abcam) and D2DR (1 : 250; Santa
Cruz). Two PSD95 antibodies of different isotypes were
used in order to enable the costaining with other markers,
which have the same isotype with one of the PSD95 anti-
bodies. Secondary antibodies including donkey anti-rabbit
Alexa Fluor 488, donkey anti-goat Alexa Fluor 555, don-
key anti-mouse Alexa Fluor 647, goat anti-mouse IgG2a
Alexa Fluor 488, goat anti-mouse IgG1 Alexa Fluor 555,
goat anti-rabbit IgG Alexa Fluor 555 and goat anti-mouse
IgG2b Alexa Fluor 647 were purchased from Thermo
Fisher Scientific and used at 1 : 1000. LMX1A/FOXA2
staining images was acquired with 10× on IX151 (Olympus,
Tokyo, Japan). Tyrosine hydroxylase/β-III tubulin staining
images were acquired with 20× on Eclipse Ti-E (Nikon,
Tokyo, Japan).
Synaptic staining images were acquired with 60x oil on
Eclipse Ti-E as z-stacks covering a range of 2.4 µm (25
slices at a step of 0.1 µm). The stack images were deconvo-
luted with HUYGENS (version 19.04; Scientific Volume Imag-
ing BV, Hilversum, Netherlands), split into three channels
that were subsequently thresholded with IMAGEJ (https://im-
agej.net). The thresholded images were input to MATLAB,
where the script (credited to M. Colom-Cadena and T.
Spires-Jones, University of Edinburgh) excluded the synap-
tic particles that were not overlapping with β-III tubulin as
noise. Colocalization or overlapping of the remaining parti-
cles was analysed in 3D. Colocalization of synapsin and
PSD95 particles was defined as < 1 µm apart with a parti-
cle of the costained marker. For each marker, the
MATLAB script outputs the total number of particles and
the number of particles colocalized or overlapped with the
costained marker, based on which the percentage of colo-
calization + overlapping was calculated.
CORIN flow cytometry
On day 16, the cells were lifted with Accutase and washed with
NDM. Cells were then centrifuged at 800 g for 2 min and
resuspended with flow cytometry buffer, which was DPBS
(without Mg2+ and Ca2+; Sigma) supplemented with 2% FBS
(Thermo Fisher Scientific). The resuspended cells were then
split into 3 tubes, one unstained, one stained with rat anti-
CORIN antibody (R&D Systems, 1 : 500) and one stained
with isotype control (R&D Systems, 1 : 500) for 15 min on
ice. The stained cells were washed with flow cytometry buffer
and incubated with donkey anti-rat IgG Alexa Fluor 488
(Thermo Fisher Scientific) for 15 min on ice. The stained cells
were then washed with flow cytometry buffer and analysed on
BD FACSCalibur (BD Biosciences, Franklin Lakes, NJ,
USA). The data were processed and plotted with FLOWJO (ver-
sion 10.0.7; BD, Franklin Lakes, NJ, USA).
Dopamine UPLC-MS/MS analysis
Conditioned media were collected on 105 DIV after a full
media change on 101 DIV. The samples were frozen on dry
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ice immediately for transportation, and subsequently
thawed and analysed on the same day at the Mass Spec-
trometry Core, Edinburgh Clinical Research Facility. DA
was extracted from cell media by solid-phase extraction
using Strata Strong Cation Exchange cartridges (55 µm,
100 mgmL−1; Phenomenex, Macclesfield, UK) and deriva-
tized with propionic anhydride prior to LC-MS/MS. The
method of Zhang et al. [47] was adapted and applied to cell
media analysis. All samples were enriched with 1 ng dopa-
mine-1,1,2,4-(dopamine-D4; Cerilliant, Round Rock, TX,
USA) as internal standard and diluted with 0.1 M
hydrochloric acid (400 µL). Cartridges were conditioned
with 0.1 M HCl (400 µL), followed by methanol (400 µL).
The sample (100 µL) was diluted with 0.1 M HCl (1 : 1),
then loaded onto the cartridge, and washed with methanol
(400 µL) and 0.1 M HCl (400 µL). The sample was slowly
eluted over 5 min by addition of acetonitrile : propionic
anhydride (90 : 10 v/v) with 2% pyridine (1 mL), followed
by a second elution with acetonitrile (400 µL). The com-
bined eluate was collected, capped and heated at 60 °C for
20 min to form a propionate derivative of DA. The solu-
tion was reduced to dryness under nitrogen at 40 °C and
reconstituted in 100 µL of water:acetonitrile (90 : 10, v/v).
A calibration standard curve of DA (0.025–10 ng) was pre-
pared alongside the samples for quantitative analysis of
DA in the samples.
Chromatographic separation was achieved on a Waters
Acquity Classic UPLC System with an Acquity UPLC
BEH C18 column (50 × 2.1 mm; 1.7 µm; Waters, Wilm-
slow, UK) protected by an Acquity in-line filter (Waters)
and operated at 45 °C. The mobile phase consisted of 0.1%
formic acid in water (A) and 0.1% formic acid in acetoni-
trile (B) at a flow rate of 0.5 mLmin−1. Gradient elution
was achieved with a total run time of 7.5 min from 15% to
85% B.
Dopamine was detected on a QTrap 5500 triple quadru-
pole mass spectrometer (Sciex, Warrington, UK) operated
in positive ion electrospray mode (5.5 kV, 500 °C, ion
source gas 1 at 60 psig and gas 2 at 40 psig). In multiple
reaction mode, transitions monitored were m/z
322.0→136.9 and m/z 326.0→140.9 for DA and DA-D4,
respectively, and peaks were eluted at 2.3 min. The peak
area ratio of DA/ DA-D4 was used to calculate the amount
of DA in the sample by linear regression analysis of a cali-
bration curve (0.025–10 ng). Scoring of LC-MS data was
performed by investigators unaware of the type of samples
(control or preconditioned).
After sample collection for conditioned media, the cul-
tures were fixed with 4% PFA and stained for TH, β-III
tubulin and DAPI. For each 24 well, a 14-mm2 area was
imaged as a representative region at 10× with tiling on Ti-
E. Number of cells were obtained by particle analysis of
the DAPI channel and analysed for their positivity of TH
and β-III tubulin. Based on the number of TH/β-III tubulin
double-positive cells of the representative image, the total
number of TH/β-III tubulin double-positive cells in each
well was estimated as used for normalization of the level of
DA detected by UPLC-MS/MS.
Electrophysiology
Visualized patch-clamp recordings from cultured neurons
were performed using an infrared differential interference
contrast imaging system. The perfusion solution contained
the following (in mM): 119 NaCl, 2.5 KCl, 1.3 Na2SO4, 2.5
CaCl2, 26.2 NaHCO3 and 1 NaH2PO4, 22 glucose, and was
continuously gassed with 95% O2 and 5% CO2, pH 7.35;
290–298 mOsm. The intracellular pipette solution for volt-
age-clamp experiments contained the following (in mM):
120.5 CsCl, 10 KOH-HEPES, 2 EGTA, 8 NaCl, 5 QX-314
Br- salt, 2 Na-ATP and 0.3 Na-GTP. For current-clamp
recordings, intracellular pipette solution contained the fol-
lowing (in mM): 126 K-gluconate, 4 NaCl, 5 HEPES, 15 glu-
cose, 1 K2SO4 7H2O, 2 BAPTA and 3 Na-ATP. pH was
adjusted to 7.2 and osmolarity adjusted to 295 mOsm. To
isolate response of NMDARs, we added to perfusion solu-
tion 50 µM picrotoxin, 20 µM NBQX, 1 µM strychnine, 1 µM
CGP-55845 and 100 µM MCPG, with no Mg2+ in perfusion
solution. To isolate response of GABAARs, we added 50 µM
APV, 20 µM NBQX, 1 µM strychnine, 1 µM CGP-55845 and
100 µM MCPG. To isolate response of GlyRs, we added
50 µM picrotoxin, 20 µM NBQX, 50 µM APV, 1 µM CGP-
55845 and 100 µM MCPG. To isolate response of AMPARs,
we added 50 µM picrotoxin, 50 µM APV, 1 µM strychnine,
1 µM CGP-55845 and 100 µM MCPG.
Whole-cell recordings
Whole-cell recordings in current-clamp and voltage-clamp
mode were performed at 32–34 °C; the patch pipette resis-
tance was 3–7 MΩ depending on particular experimental
conditions. Series resistance was monitored throughout
experiments using a + 5 mV step command, and cells with
very high series resistance (above 25 MΩ) or unstable hold-
ing current were rejected.
Outside-out and nucleated patch recordings
Outside-out patches and cell membrane bags containing
intact nucleus and cytoplasm (nucleated patches) were
pulled from cultured neurons, and recordings were per-
formed in voltage-clamp mode (Vhold −60 or −70 mV, as
indicated). Solution exchange experiments were performed
as described in our earlier published protocol [48]. Briefly,
we used a θ-glass application pipette with ~ 200 µm tip
diameter attached to the micromanipulator. The position of
the pipette was controlled by piezoelectric element (the
speed of switch was 50–100 µs). One pipette channel was
filled with the bath artificial cerebrospinal fluid solution;
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another channel was loaded with neuroreceptors’ ligands.
Pressure was regulated by a PDES-02DX pneumatic
microejector (npi) using compressed nitrogen separately in
each of two channels.
We have chosen nucleated patches rather than outside-
out patches due to the following considerations. Since
nucleated patch preserves a part of intracellular milieu, this
allows persistence of modulatory signalling from cytoplas-
mic actors, and therefore more physiological receptor
response. However, in experiment on direct NMDAR block
by DA we used outside-out rather than nucleated patches:
since DAR-initiated inhibition of NMDARs requires
involvement of cytoplasmic signalling cascades [49–51], this
preparation makes sure that all cytoplasmic structures are
destroyed.
Acquisition and analysis
Recordings were obtained using a MultiClamp 700B
Amplifier (Molecular Devices, San Jose, CA, USA), filtered
at 4–8 kHz, digitized at 10 kHz and stored on a PC.
PCLAMP/CLAMPFIT 10× software (Molecular Devices) was
used for data storage and offline analysis. Activation of
neuroreceptors at outside-out and nucleated patches evoked
macroscopic responses, where ’peak response’ was obtained
as a difference between baseline (average for 50 ms before
application of NMDAR ligands) and maximum evoked
current. For automatic detection of spontaneous postsy-
naptic currents (sPSCs), we used a Clampfit 10 built-in
event detection algorithm with a detection template gener-
ated by averaging of 10–15 events with amplitude higher
than doubled amplitude of peak-to-peak noise in given
recording. To quantify charge transfer by EPSP events and
changes in cell membrane capacitance due to neurotrans-
mitter vesicle release, we used area under the response
curve (AUC). This was obtained as Σ (an-ac), where an is a
current (or capacitance) value at a given time point after
stimulation, and ac is a baseline average for 100 ms before
stimulation.
The open-time fraction (OTF) of single NMDAR chan-
nels was calculated as tf/to, where tf is a full time of obser-
vation, and to is a time in an open state. to was counted
using a detection threshold of 1.5 pA more negative than
mean baseline and a minimum opening time of 0.2 ms.
It was virtually impossible to determine accurately the
number of channels in a membrane patch; however, in our
preparation the vast majority of channel openings were sin-
gle-level events. In a case where there were multiple levels
of channel openings, only level with highest conductance
was analysed. This prevented us from overestimation of
opening frequency increase, since in multichannel patch,
increased opening frequency would be accompanied by
increase in proportion of multilevel events. Values for the
average open time of single channel were obtained with
threshold-detection algorithm of CLAMPFIT 10× software.
To fit the concentration–response curve of NMDA







where Cl is concentration of a given ligand, IC50 is the
concentration of a ligand generating half-maximum
effect, and n is Hill’s coefficient.
For numerical fitting of decay profiles of phasic
responses recorded from NPs, we applied a generalized
biexponential fitting approach:
ΔI ¼ a1et=τ1 a2et=τ2 (2)
In (Eq. 2), ΔI is a difference between current recorded at
baseline and at time t, e is Euler’s constant, a is the fitting
constant, and τ is the decay time constant. To quantify
changes in response kinetics under different experimental
conditions (application of pharmacological agents and/or
changes of holding voltage), we used a ’fast decay compo-
nent-to-slow decay component’ ratio of fitting constants (a).
To test whether the effect of simultaneous application of
DA and memantine at NMDARs is independent or not (i.e.
whether these two drugs compete for the same binding site),
we compared the standard error of sum of their independent
effects (SEsum) with standard error of the effect triggered by
their joint application. SEsum of effects x and y when the





s2x þ s2y þ 2s2xy
q
(3)
In (Eq. 3), sx is a standard deviation of effect x; sy is a
standard deviation of effect y; s2xy is a covariance of x, y. If








Strychnine, tetrabenazine (TBZ), memantine, GGP-
55845, NBQX, DNQX, APV, picrotoxin, MCPG, QX-314
bromide, NMDA, glycine, (S)-sulpiride, felbamate, PMPA
and SCH-23390 were purchased from Tocris Bioscience
[52]. All other chemicals were purchased form Sigma-
Aldrich, unless otherwise indicated. All data are given as
mean  standard error of mean. Statistical comparisons
were made with Student’s unpaired t-test, unless different is
indicated in the text; P-value of ≤ 0.05 was taken as a
threshold of significance.
Results
As a preliminary control, we assessed the quality of
the midbrain DA differentiation of hESCs during both
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progenitor stage and neuronal stage. On day 11, the
cells were highly positive for LMX1A and FOXA2,
suggesting their identity as midbrain DA progenitors
(Fig. 1A) [46,53]. On day 16, flow cytometry of floor
plate marker CORIN indicated the midbrain DA pro-
genitors were of floor plate identity (Fig. 1B) [54]. On
day 44, the midbrain DA culture was highly positive
for DA marker TH (Fig. 1C) and expressed a high
level of DA neuronal markers NURR1, SOX6,
VMAT2 and DAT [44]. The high purity of TH-posi-
tive neurons was retained in further differentiation to
day 77 (Fig. 1C).
In the first stage of our study, we performed charac-
terization of electrophysiological properties of hESC-
derived DA neurons. We tested, whether they carry
functional ionotropic excitatory and inhibitory recep-
tors of two main types: glutamate-sensitive (AMPARs,
NMDARs) and GABA-sensitive (GABAARs). To do
this, we applied receptor-specific ligands at nucleated
membrane patches. Application of 100 µM AMPA,
100 µM GABA and 100 µM NMDA + 100 µM Gly trig-
gered transmembrane currents, then suppressed by
specific antagonists of corresponding receptors: NBQX
(20 µM), PTX (50 µM) and APV (50 µM), respectively
(Fig. 2A).
In the second stage, we tested whether DA neurons
can generate APs. Indeed, in response to current injec-
tion we observed APs, which were suppressed by 1 µM
TTX, demonstrating the presence of voltage-gated
sodium channels and their decisive role in AP genera-
tion (Fig. 2B).
Therefore, we next examined whether cultured DA
neurons can generate APs in response to field stimula-
tion, that is, whether they form a functional neural
network with working synapses (Fig. 2C). To do this,
we delivered a series of five field stimuli with 50-ms
intervals. We tried to generate APs with this stimula-
tion pattern in 21 cells (12 at 66 DIV, 9 at 100 DIV),
which displayed APs in response to current injection,
but all our attempts were fruitless. However, 50 µM
Fig. 1. Quality control of midbrain DA neuron differentiation. (A) Day 11 coimmunostaining of LMX1A and FOXA2 suggested a
homogeneous population of midbrain DA progenitors. (B) Day 16 flow cytometry of CORIN indicated the vast majority of midbrain DA
progenitors were of floor plate identity. (C) Typical day 44 and 77 coimmunostaining of DA marker TH and pan-neuronal marker β-III tubulin
in mDA cultures plated at 25 000 cells per cm2 on 8-well glass bottom plates.
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PTX added to the perfusion solution triggered AP fir-
ing in 8 of 21 cells (4/12 at 66 DIV, 4/9 at 100 DIV).
The 50 µM APV, added after PTX, did not generate a
significant difference in a number of the APs per stim-
ulation train: 2.375  0.183 for PTX vs. 1.75  0.164
for PTX + APV, P = 0.095, n = 8, Student’s paired t-
test. In contrast, 20 µM NBQX, added after APV, fully
suppressed EPSPs in all 21 cells tested.
These initial results suggest that normal synaptic sig-
nalling in a cultured network of hESC-derived DA
neurons is precluded due to the weak NMDAR func-
tion. Hence, we set out to clarify the factors determin-
ing such a poor NMDAR signalling. To find out
whether this is due to under-differentiation of stem
cells into neurons, we repeated all the experiments on
66 DIV and 100 DIV cultures. However, the only
experimental readout with a significant difference
between 66 DIV and 100 DIV was a frequency of
GABAAR-mediated spontaneous EPSCs (sEPSCs)
under elevated Ca2+ concentration (Fig. 4).
Hence, as a first step, we tested whether DA neu-
rons possess functional synapses. To do this, we per-
formed immunostaining for PSD-95 (scaffolding
element of postsynaptic density) and synapsin (presy-
naptic protein implicated into vesicle release of
neurotransmitters) on 66 DIV. Close proximity of
PSD-95 and synapsin staining foci should mark func-
tional synapses. Indeed, in our experiments we found
that 27.73  2.23% of PSD-95 foci are placed within
1 µM distance from synapsin, and 23.89  3.89% of
synapsin foci are placed within 1 µM distance from
PSD-95 (Fig. 3A, n = 6 fields from two cultures).
Average numbers of 7.14  0.89 PSD-95 particles were
in close proximity with synapsin and 7.07  0.88
synapsin particles were in close proximity with PSD-95
per 10 µm3 in our preparation suggest numerous func-
tional synapses within a neural network.
Next, we tested whether cultured neurons have func-
tional presynaptic neurotransmitter release machinery.
To do this, we recorded changes in a whole-cell mem-
brane capacitance (Cm) in response to a field stimula-
tion train of five stimuli with 50-ms intervals (Fig. 3B).
To quantify the input of the Ca2+-dependent mecha-
nism of vesicle release, we repeated the experiment
under normal (2 mM) and elevated (5 mM) Ca2+ con-
centration, and then calculated the normal/elevated
ratio of AUC. The stimulation train triggered a clear
transitional increase in Cm, whereas elevation of extra-
cellular Ca2+ induced a significant increase in AUC
(Fig. 3B). The control vs. elevated Ca2+ ratio was
Fig. 2. NMDARs, despite being abundant at cell membrane, play a minor role in EPSP and AP generation. (A) Cultured DA neurons carry
fully functional excitatory and inhibitory ionotropic receptors at their surface. Application of corresponding receptor agonist(s): 100 µM GABA,
100 µM AMPA, 100 µM NMDA + 100 µM glycine at nucleated membrane patches triggers current flow through GABAARs, AMPARs and
NMDARs, respectively. Further action of selective antagonists (50 µM PTX, 20 µM NBQX, 50 µM APV) confirms generation of observed
transmembrane current exclusively by correspondent receptor. Scale bars in A apply to all traces. (B) APs triggered by step current
injection. 1 µM TTX fully suppresses APs, confirming involvement of voltage-gated sodium channels. (C) EPSP generation by field
stimulation. No APs were obtained under control conditions, whereas block of GABAARs with 50 µM PTX triggered AP generation.
Subsequent application of 50 µM APV demonstrates nonsignificant input of NMDARs into EPSP and AP generation machinery (see text for
details and statistical data). In contrast, 20 µM NBQX, being added to perfusion solution, reveals a major input of AMPARs into EPSP
formation.
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obtained as 1.89  0.15 for 66 DIV and 2.16  0.1 for
100 DIV (n = 7 for both cases), with no significant dif-
ference between the two periods in culture: P = 0.17
for 66 DIV vs. 100 DIV, Student’s t-test. This con-
firmed the functionality of the classical Ca2+-depen-
dent presynaptic vesicle release mechanism.
To further clarify synaptic functionality, we tried to
record sPSCs generated by GABAARs, AMPARs and
NMDARs, under normal and elevated Ca2+ concentra-
tions (Fig. 4). Our recordings revealed the presence of
GABAAR- and AMPAR-mediated sPSCs, which were
suppressed by specific antagonists PTX and DNQX,
respectively (Fig. 4A,B). Elevation of the extracellular
Ca2+ concentration has caused a significant increase in
sPSC frequency (Fig. 4C): 8.19  1.14 Hz under con-
trol vs. 11.91  1.39 Hz with elevated Ca2+, P = 0.029
for GABAARs 66 DIV; 11.85  1.26 Hz vs.
18.87  1.04 Hz, P = 0.021 for GABAARs 100 DIV;
2.83  0.49 Hz vs. 3.97  0.57 Hz, P = 0.0007 for
AMPARs 66 DIV; and 3.39  0.39 Hz vs.
5.6  0.55 Hz, P = 0.023 for AMPARs 100 DIV, n = 6
for all cases, Student’s paired t-test. In this experiment,
we observed a significant difference between sPSC
frequency for GABAARs at 66 and 100 DIV under ele-
vated Ca2+ concentration: 11.91  1.39 vs.
18.87  1.04 Hz, respectively; P = 0.0025, n = 12, Stu-
dent’s t-test. In contrast, no spontaneous activity was
observed when we isolated NMDARs pharmacologi-
cally (data not shown).
Therefore, we found that cultured DA neurons bear
synapses with functional GABAARs and AMPARs at
the postsynaptic side and confirmed the release of both
inhibitory (GABA) and excitatory (glutamate) neuro-
transmitters from the presynapse.
To explain the absence of NMDAR-generated post-
synaptic response, we next hypothesized that, despite
being abundant at the cell surface (Fig. 2A),
NMDARs have too low rate of postsynaptic localiza-
tion. To test this, we performed coimmunostaining of
NR1 and NR2 NMDAR subunits and PSD-95 protein
(Fig. 5A). We found that 0.75  0.18% NMDAR-
staining foci overlap with PSD-95 staining, and
0.85  0.19% of PSD-95 staining foci overlap with
NMDAR staining (n = 10 fields from three cultures).
However, is this overlap rate low enough to prevent
triggering of NMDAR-generated PSCs? To clarify
Fig. 3. hESC-derived DA neurons possess functioning presynaptic mechanism of vesicular neurotransmitter release. (A) Example image of
coimmunostaining for PSD-95 (marker of postsynaptic densities) and synapsin (marker of presynaptic terminals) at DIV 77. Close proximity
(≤ 1 µm) of PSD-95 (green) and synapsin (red) foci suggests availability of functional synapses in cell culture. Blue: staining for β-III tubulin,
revealing cell somata and neurites. (B) Changes in whole-cell membrane capacitance evoked by stimulation series confirm elevated intensity
of vesicle release. Shadows of blue: ten consequent individual traces; red: averaged trace. Elevated Ca2+ causes a significant increase in
the area under the averaged curve (see text for statistics), thus confirming the involvement of presynaptic Ca2+-dependent mechanisms.
Top: 66 DIV culture; bottom: 100 DIV culture. Axis labels apply to all four plots.
3279FEBS Letters 594 (2020) 3272–3292 ª 2020 The Authors. FEBS Letters published by John Wiley & Sons Ltd
on behalf of Federation of European Biochemical Societies
Y. Chen et al. Why NMDARs are silenced in cultured dopamine neurons
this, we performed coimmunostaining for the PSD-95
protein and α1 GABAAR subunit (Fig. 5B), since clear
GABAAR-mediated synaptic activity was registered in
our previous experiment (Fig. 4A). Here, we found
that 14.81  1.65% GABAAR-staining foci overlap
with PSD-95 staining, and 13.04  1.04% of PSD-95
staining foci overlap with GABAAR staining (n = 8
fields from two cultures). The difference between the
overlap rates with PSD-95 for NMDAR and for
GABAAR was highly significant: P < 0.0001 for both
‘receptor over PSD-95’ and ‘PSD-95 over receptor’
comparisons, Student’s t-test.
Fig. 4. Spontaneous activity confirms the presence of functional synapses in DA neurons. (A): GABAAR-mediated sIPSCs. From top to
bottom: control, elevated Ca2+, PTX 50 µM. (B) AMPAR-mediated sEPSCs. From top to bottom: control, elevated Ca2+, DNQX 20 µM. (C)
Statistical summary for A and B: frequency of postsynaptic currents. Asterisks denote significance of difference between ‘control’ and
‘elevated Ca2+’ conditions. *P < 0.05, ***P < 0.001, n = 6, Student’s paired t-test.
Fig. 5. Postsynaptic receptors in hESC-derived DA neurons. Example images of coimmunostaining for PSD-95 (marker of postsynaptic
densities, green) and three receptors under study (red) in 77 DIV cultures – (A) NMDAR (staining for NR2A and NR2B subunits); (B)
GABAAR (staining for α subunit); and (C) D2R. Blue: staining for β-III tubulin, revealing cell somata and neurites.
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However, even a single opening of NMDAR chan-
nel can be enough for proper transmission of synaptic
signal [55]. Hence, relatively low (if compared to
GABAARs) level of NMDAR immunostaining would
not cancel the ability of glutamatergic signals to evoke
excitatory responses in postsynaptic cell; we thus
decided to test the functional role of NMDARs with
electrophysiological methods.
We assumed that there are the following possible
mechanisms preventing normal NMDAR-mediated
signalling.
First, activation of postsynaptic dopamine receptors
of type 2 (D2R) by DA was shown to suppress
NMDAR effects [50,56]. To substantiate this hypothe-
sis, we performed coimmunostaining of D2R and
PSD-95 (Fig. 5C) at 77 DIV. We found that
10.84  3.13% of D2R staining foci overlap with
PSD-95 staining, and 11.49  3.38% of PSD-95 foci
overlap with D2R staining (n = 7 fields from two cul-
tures), thus giving credibility to this assumption.
Second, DA neurons may release an amount of DA
high enough to block NMDARs directly [50,57]. To
substantiate this hypothesis, we performed HPLC mea-
surement of DA concentration in cell culture media.
In this experiment, we detected a 1462.33  365.58 nM
(n = 2) of DA at 105 DIV, with no DA detection in
control media (Fig. 6). With consideration of the
native DA concentration in cerebrospinal fluid of
2–5 nM [58,59] and the brain extracellular volume frac-
tion of ~ 0.2 [60], the results of the HPLC experiment
suggest our hypothesis to be plausible.
Third, astroglial cells were shown to regulate the
amount of NMDAR coagonists Gly and D-serine (D-
Ser) directly by producing these compounds [61,62], or
via the control over synthesis of substrate (such as L-
serine) needed for production of the coagonists [63].
Fig. 6. Detection of DA in cell culture conditioned media by HPLC. (A) Conditioned media from 105 DIV cell culture. Dopamine
quantification generated values of 224  56 ngmL−1, or 1671  587 ng/106 cells, or 1462  365 nML−1. (B) Control media. Right panels in
A and B represent measurements of respective internal standard (1 ng of D4-dopamine).
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Thus, the glia-free culture may not supply enough
coagonists for proper NMDAR functioning.
To test these assumptions, we first attempted to
record GlyR-mediated sPSCs in cultured neurons. How-
ever, neither 66 DIV (five recordings) nor 100 DIV
(seven recordings) cells displayed visible postsynaptic
events. But was this due to low Gly release in synapses,
or due to the absence of GlyRs in cultured neurons? To
clarify this, we performed an agonist-application experi-
ment with nucleated patches. In this experiment, appli-
cation of 100 µM Gly induced a clear inward current,
fully suppressed by 1 µM strychnine (Fig. 7A). This sug-
gested that the absence of glycinergic sPSCs was most
likely due to a deficit of released Gly.
To test whether neuron-released DA causes a direct
block of NMDARs, we repeated the rapid agonist-ap-
plication experiment at nucleated patches, applying
100 µM NMDA + 100 µM Gly and 100 µM NMDA +
100 µM Gly + 500 µM DA (Fig. 7B). We found that
DA decreases NMDAR response amplitude to
0.12  0.03 of control: P < 0.0001 for the difference
from unity, n = 6, Student’s paired t-test.
Furthermore, we set out to comprehend whether
under control conditions in our preparation NMDARs
make a significant input into EPSC generation. To
achieve this, we generated EPSPs with a series of five
electrical stimuli 50 ms apart, using an experiment/con-
trol AUC ratio for quantification of the impact of phar-
macological interventions (Fig. 7C). Fifty micro molar
APV in this experiment did not exert a significant
impact on AUC ratio: 0.95  0.13 for DIV 66, P = 0.75
for the difference from unity; and 0.9  0.11 for DIV
100, P = 0.4 for the difference from unity; n = 6 for
both cases. There are two possible explanations for this
result: first, due to the absence of functional NMDARs
(but this is at odds with our previous data demonstrat-
ing NMDAR activity in patches; see Fig. 2A); and sec-
ond, NMDARs under control conditions can be already
suppressed due to the presence of an unknown factor.
Hence, to determine whether DA could be this sup-
pressive factor, we tested whether DA receptors
(DARs) of cultured neurons generate an inhibitory
tone sufficient to suppress NMDAR signalling (Fig. 7
D). The block of DARs’ activity with 10 nM SCH
23390 (SCH) + 10 µM sulpiride (Sul) generated a dis-
cernible, but not significant, elevation of AUC above
control values (Fig. 7D,K,L); AUC ratio for DIV 66:
1.37  0.16, P = 0.072 for the difference from unity;
n = 6, Student’s paired t-test for this and all further
AUC comparisons; and for DIV 100: 1.18  0.099,
P = 0.135 for the difference from unity. The 50 µM
APV, added after SCH + Sul, decreased the AUC
ratio to 1.26  0.18 for DIV 66 and to 1.15  0.15 for
DIV 100; there was no significant difference in AUC
under APV from SCH + Sul and from control:
P > 0.2 for all comparisons.
Next, we examined whether suppression of
NMDAR function can be overruled by additional
amounts of NMDAR coagonists. First, we performed
a 20-min incubation in 1 mM D-Isoleucine (D-Ile), since
it was shown to stimulate release of Gly and D-Ser
from primary neurons [64] (Fig. 7E,K,L). Incubation
with D-Ile induced a significant increase in the AUC
ratio: to 1.48  0.1 for DIV 66, P = 0.0047 for the dif-
ference from unity; and to 1.42  0.17 for DIV 100,
P = 0.048 for the difference from unity. Application of
APV returned AUC to control values: 0.88  0.14 for
DIV 66 and 1.07  0.12 for DIV 100, P > 0.4 for the
difference from unity for both cases. However, it is
unclear whether incubation with D-Ile can reproduce
the concentrations of NMDAR coagonists characteris-
tic for neural tissue in vivo. Since native concentrations
of Gly and D-Ser in substantia nigra – the brain area
with abundant DA neurons – were found as
5.6  1.3 µM (Gly) and 5.3  1 µM (D-Ser) [65], we
repeated the experiment adding 5 µM Gly + 5 µM D-Ser
to the perfusion solution (Fig. 7F,K,L). We found that
NMDAR coagonists increase the AUC ratio signifi-
cantly: to 1.77  0.15, P = 0.004 when compared to
unity for DIV 66; and to 1.74  0.19, P = 0.011 for
DIV 100. Next, we tested whether the combined effects
of DARs and Gly + D-Ser make a significant impact
in our preparation. To do this, we blocked DARs with
SCH + Sul after application of Gly + D-Ser (Fig. 7F,
K,L). Inactivation of DARs did not cause a significant
difference in AUC. The AUC ratio for Gly + D-Ser +
SCH+Sul was obtained as 1.82  0.17 for DIV 66
and 2.01  0.13 for DIV 100, P > 0.3 in both cases
when compared to correspondent values for Gly + D-
Ser. Therefore, since antagonists of DA receptors
(SCH and Sul) do not demonstrate a significant impact
on NMDAR function when it was magnified by ele-
vated concentrations of Gly + D-Ser, the possible
effect of elevated DA concentration in cell culture
medium is not transferred through DA receptors.
Finally, we assessed the direct effect of DA released
upon field stimulation on postsynaptic NMDARs
(Fig. 7G,K,L). To do this, we performed a 30-min
incubation with 1 µM TBZ, which suppresses vesicle
release of DA [66]. TBZ increased significantly the
AUC ratio: to 1.3  0.12, P = 0.048 when compared
to unity for DIV 66, and to 1.26  0.06, P = 0.007 for
DIV 100. Further application of APV made the differ-
ence in AUC from control values nonsignificant:
0.89  0.05 for DIV 66 and 0.96  0.12 for DIV 100,
P > 0.08 for both cases when compared to unity.
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Fig. 7. NMDAR coagonists and DA modulate NMDAR signalling. (A) 100 µM Gly evoke inward current in nucleated patch, which is fully
suppressed with 1 µM Str, thus confirming the presence of functional GlyRs in cultured neurons. 2.5-s scale bars apply to A and B. (B)
500 µM DA reversibly suppress NMDAR response generated in outside-out patch by application of 100 µM NMDA + 100 µM Gly. (C) Block of
NMDARs with 50 µM APV does not make a significant impact on the area under the EPSP curve. 100-ms scale bars apply to C-I, 5-mV scale
bars apply to C-G. In C-I stimulation, artefacts are blanked for clarity purpose. (D) Block of DARs with 10 nM SCH and 10 µM Sul induces
nonsignificant increase in EPSP amplitude, which is then suppressed by APV. (E) 20-min incubation in 1 mM D-Ile induces an increase in
EPSP amplitudes, which was reverted by APV. (F) 5 µM Gly + 5 µM D-Ser increase EPSP amplitudes, which are further increased by DARs
block with SCH + Sul. (G) 20-min incubation in 1 µM TBZ induces an increase in EPSP amplitudes, which is reverted by APV. (H) 5 µM
Gly + 5 µM D-Ser added to perfusion solution after 30-min. incubation in TBZ induces an increase in EPSP amplitudes and allows AP firing in
response to field stimulation, whereas APV turns EPSP amplitudes back to control. 20-mV scale bars apply to H and I. (I) Series of rapid
applications of Glu + Gly generate APs without a need to modify DAR signalling. (J) 5 µM Gly + 5 µM D-Ser and 30-min incubation in TBZ
allow propagation of pharmacologically isolated NMDAR-mediated sPSCs (top trace), then fully suppressed by APV (bottom trace). (K)
Statistical summary for D-H, 66 DIV cultures. Areas under the EPSP curve are normalized to those obtained under control conditions. Bar
pattern legend apply to J and K. (L) Same as J, for 100 DIV cultures. Asterisks denote significance of difference between bars; *P < 0.05,
**P < 0.01, ***P < 0.001, n.s. – not significant, n = 6, Student’s paired t-test.
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Hence, we tested three possible factors that could
silence NMDARs, and found that two of them – (a)
lack of NMDAR coagonists and (b) direct suppression
of NMDARs by synaptically released DA – made a
significant impact on NMDAR function. However, no
APs were observed in the experiments described above;
that is, we still did not establish what prevents AP
generation. We therefore decided to combine the
effects of two significant factors. To do this, we
repeated the experiment on EPSP AUC ratios with
incubation in TBZ and application of Gly + D-Ser
(Fig. 7H,K,L). The TBZ + Gly+ D-Ser caused a con-
siderable increase in AUC; the AUC ratio was
obtained as 2.42  0.17 for 66 DIV, P = 0.0005 for
the difference from unity, and as 2.33  0.12,
P = 0.0001 for 100 DIV. Further application of APV
returned AUC to control values: 0.82  0.2 and
0.91  0.17 for 66 and 100 DIV, respectively, P > 0.3
for the difference from unity in both cases. And in this
experiment, we observed AP generation in four cells
out of six recorded for DIV 66 and in five out of six
for DIV 100: see an example trace in Fig. 7H.
We therefore concluded that lack of NMDAR coag-
onists and a direct suppression of NMDAR function
by DA released from neurons are the factors which,
being combined, prevent neurons from firing. To con-
firm this, we conducted two control experiments.
First, we performed a series of rapid applications of
100 µM glutamate + 100 µM Gly at an isolated cell
(connections to neighbouring neurons were cut with a
blunt electrode); this should excite NMDARs without
concomitant release of DA in synapses. In this experi-
ment, four out of six recorded cells (DIV 66) and five
out of eight cells (DIV 100) generated APs: refer to
Fig. 7I for example trace. Second, we performed a
whole-cell voltage-clamp recording after incubation
with TBZ and adding Gly + D-Ser to the perfusion
solution, with a ligand cocktail isolating NMDAR
response. In this experiment, we set out to record
NMDAR activation by spontaneous Glu release from
presynaptic buttons. Such this type of NMDAR
response (sPSCs) is difficult to obtain in any neuronal
specimen, the probability of false-negative output was
quite high. But, surprisingly, in three out of six cells
(DIV 66) and five out of nine cells (DIV 100), we
observed sPSCs; subsequent block of these sPSCs by
APV confirmed their generation exclusively by
NMDARs (Fig. 7J).
To further clarify the phenomenon of interneuronal
crosstalk silencing in DA neuronal network, we stud-
ied the molecular mechanism of suppression of
NMDAR activity by DA. At first, we tested whether
DA blocks NMDAR functioning via the binding
inside the ion channel. To do this, we recorded a cur-
rent flow through NMDARs under nonsaturating con-
centrations of DA (200 µM) and NMDAR open-
channel blocker memantine (Mem, 0.5 µM). In this
experiment, an additive effect of DA and Mem (when
they are applied together) implies independent action
mechanisms; otherwise, these two compounds would
compete for the same or nearby binding sites, that is
DA likely binds inside the open NMDAR channel.
Our data suggest the first scenario (Fig. 8A,B). Being
applied separately at outside-out patches, DA and
Mem suppressed the effect of 100 µM glutamate
(Glu) + 100 µM Gly by 28.5  5.1% and 42.1  6.9%,
respectively, whereas their joint application reduced
the NMDAR-transmitted current by 72.4  7.6%.
The last value does not differ significantly from the
sum of independent effects: 72.4  7.6% vs.
70.6  7.8%, P = 0.85, n = 7, Student’s t-test. The
SEsum value of 7.8% calculated with Eq. (4) for inde-
pendent variables (see Materials and methods)
appeared to be very close to that obtained in experi-
ment for the joint application (7.6%), thus giving an
additional support to our hypothesis about separate
action sites of DA and Mem.
We therefore set out to test possible impact of DA
on glutamate and glycine binding sites located at outer
NMDAR surface. To do this, we analysed an
NMDAR response decay kinetics due to dissociation
of Gly and Glu. We performed a rapid solution appli-
cation experiment on outside-out patches where the
applied solution contained both Glu and Gly, whereas
perfusion solution contained only one of these ligands.
To test possible voltage dependence of DA effect, we
repeated the experiment at −60 and +60 mV holding
voltage (Fig. 8C,D). We found that 200 µM DA signifi-
cantly augmented the fast-to-slow decay component
ratio (DCR), that is accelerated the response decay of
the current induced by the application of Gly but not
Glu: see Fig. 8C legend for detailed description of cal-
culation paradigm. The numerical output on DCR
modulation was as follows: for Gly application at
−60 mV 1.32  0.23 under control vs. 2.35  0.35
with DA, P = 0.033; at +60 mV 1.19  0.1 vs.
1.91  0.22, P = 0.043; for Glu application at −60 mV
1.15  0.14 under control vs. 1.17  0.15 with DA,
P = 0.86; at +60 mV 1.2  0.16 vs. 1.25  0.15,
P = 0.67; n = 7 for all comparisons, Student’s paired
t-test. This experimental result supports a hypothesis
where the DA interaction is with the Gly binding site
rather than the binding site of Glu.
To probe the hypothesis deeper, we performed an
isobolic concentration–response analysis [67–69] of
mixtures of DA with NMDAR antagonists with
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different action mechanisms: Mem (open-channel
blocker), PMPA (competitive antagonist of Glu bind-
ing site) and felbamate (Flb, competitive antagonist of
Gly binding site). In this analysis paradigm, the con-
centration–effect curve of the drug mixture, which is
significantly different (lower or higher) from a straight
line connecting the effect values of pure components
of the mixture, testifies to a nonadditive interaction
(synergy or antagonism) of the components. This, in
turn, suggests a common action site [67,70].
To perform the test under more physiological condi-
tions, we evoked NMDAR response with native con-
centrations of the receptor’s ligands characteristic for
substantia nigra: 2.5 µM Glu + 5 µM Gly + 5 µM D-Ser
[65]. However, with these concentrations of the ago-
nists in experiment with rapid solution application (as
at Fig. 2A) the NMDAR response amplitude and, as a
sequence, signal-to-noise ratio were too small to gener-
ate a legible output upon application of antagonists,
especially in their high concentrations. We therefore
used a different experimental approach: continuous
recording of single-channel NMDAR openings in out-
side-out patches with fluctuations of an OTF as a
quantitative indicator of the antagonists’ effect
(Fig. 9).
At a first stage, we generated concentration–re-
sponse curves for DA, Mem, Flb and PMPA and fit-
ted them with a Hill equation, to obtain IC50 for
Fig. 8. Action mechanism of DA at
NMDAR. (A) Example NMDAR-mediated
currents recorded from the same
nucleated patch, partially suppressed by
DA (200 µM) and Mem (0.5 µM). 100-pA
scale bars apply to all traces in A. (B)
Statistical summary for A: percentage of
control response suppression by DA and
Mem. Height of the rightmost bar was
obtained as a sum of DA and Mem
effects when compounds were applied
separately; SE value for this bar was
calculated with Eq. (3) (see Materials and
methods). (C) Top: analysis paradigm for
NMDAR response decay kinetics with
biexponential fitting. Dashed lines through
data points: best-fit biexponential
functions. Decay component ratio of fast
(τ = 3.73) to slow (τ = 17.54) component
generated by NMDAR ligands was
obtained as 132.1/108.1 = 1.22;
application of DA augmented the decay
component ratio to 102.1/39.3 = 2.6.
Colour codes for control and DA apply to
all traces in C. Medium: rapid application
of 100 µM glycine at −60 and +60 mV
membrane potential, 100 µM glutamate
added to both switching solutions. Grey:
traces obtained under DA normalized to
peak amplitude of control response to
illustrate the impact of DA on decay
kinetics. Bottom: rapid application of
100 µM glutamate at −60 and +60 mV
membrane potential, 100 µM glycine added
to both switching solutions. (D) Statistical
summary of C. Asterisks denote
significance of difference between bars:
*P < 0.05, n.s. – not significant, Student’s
paired t-test.
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antagonists applied alone (Fig. 9B). The IC50 values
were fitted out as follows: 88.76  7.47 µM for DA,
1.21  0.13 µM for Mem, 1.25  0.17 mM for Flb and
2.91  0.36 µM for PMPA. On top of that, the experi-
ment with DA displayed a significant effect of 1 µM
DA under native concentrations of NMDAR agonists:
96.19  1.3% of NMDAR effect remained, P = 0.033
for the difference from 100%, n = 6, Student’s paired
t-test. This confirms a significant impact of DA con-
centration found in cell culture medium (1.4 µM,
Fig. 6) on NMDAR functioning.
Next, we composed three mixtures of DA and other
antagonists: 75% DA + 25% of an antagonist,
50% + 50% and 25% DA + 75% of an antagonist;
all compounds were taken in concentrations equal to
their IC50 values. The effect of these mixture was
Fig. 9. Combined effects of NMDAR antagonists. (A) Example single-channel NMDAR recordings. Top four traces: effect of DA
administered alone. From top to bottom: control, DA 10 µM, DA 100 µM, washout. Three bottom traces: effect of a mixture DA/ Flb in
concentrations equal to their IC50s. From top to bottom: 75% DA/ 25% Flb; 50% DA/ 50% Flb; 25% Da/ 75% Flb. Scale bars apply to all
traces. (B) Dose–response curves for antagonists’ impact on NMDAR OTF. Vertical axis labels apply to all panels. (C) Effect of combinations
of IC50 for DA + Mem, DA + Flb and DA + PMPA. Dots on axes represent IC50 of DA (vertical axis) and other antagonist (horizontal axis)
administered alone. The solid line connecting these dots represents the theoretical line of additivity for a continuum of different mixtures of
antagonists’ IC50s. The dashed lines represent 95% confidentiality corridor for the corresponding solid line. In each plot, three dots between
axes depict the experimentally obtained effect of IC50 mixtures of DA and other antagonist (see text for more details). From left to right, at
each plot: 75% DA/ 25% of other antagonist, 50%/ 50%, 25% DA/ 75% of other antagonist. Position of each dot at a vector directed from
the origin of coordinates to solid line represents a proportion of NMDAR OTF left intact after application of corresponding mixture. The IC50
mixture for DA-Flb pair (medium panel) displays a supra-additive interaction: dots depicting effects of 50%/ 50% and 25% DA/ 75% Flb
ratios are significantly below the theoretical line of additivity (marked by asterisks, P < 0.05, Student’s t-test, n = 6).
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compared with the theoretical line of additivity con-
necting IC50 values of the mixture components applied
alone (Fig. 9C). Mixtures of 50% DA + 50% Flb and
25% DA + 75% Flb displayed a significant difference
from half-maximum effect. For 50%/50% mixture, the
remaining OTF was 33.77  6.05% of control,
P = 0.043 for the difference from half-maximum
effect; for 25%/75% mixture, the remaining OTF was
39.4  3.93% of control, P = 0.047 for the difference
from half-maximum effect; n = 6 for both cases, paired
Student’s t-test. This result confirmed DA antagonist
action at NMDAR to be associated with Gly binding
site.
Discussion
In the current study, we used an established protocol
that efficiently generates uniform DA neurons from
hESCs expressing key developmental and biochemical
markers [44,53,54]: see Fig. 2. Electrophysiological sig-
nature of our cultured neurons was also similar to DA
neurons generated from hESCs by other groups and to
that of native DA neurons. This signature includes the
presence of functional NMDARs and AMPARs
[27,71], GABAA receptors [36,72], GlyRs [37,73] and
DA corelease with GABA [38] and glutamate [39]. We
therefore concluded that neuronal cells differentiated
in our study are biochemically and functionally similar
to native DA neurons.
In this project, we revealed two main factors that
prevent synaptic crosstalk in DA neural cultures when
overlapping: lack of NMDAR coagonists and inhibi-
tion of NMDARs by synaptically released DA.
It is widely accepted that PSD-95 is a key element
of postsynaptic density associated with postsynaptic
NMDARs and GABAARs [74,75]. Hence, a relatively
high level of overlap between NMDAR and GABAAR
immune signal with that of PSD-95, observed in our
study, is important evidence of morphologically devel-
oped synapses. Although the Dale’s principle ‘One
neuron, one neurotransmitter’ has been challenged
decades ago, corelease of DA and glutamate was con-
firmed experimentally only quite recently [39,40]. From
the two modes of glutamate-DA cotransmission evi-
denced so far: release from the different terminals or
from the same terminal [76], our data suggest the pres-
ence of the latter mode, due to the significant impact
of TBZ on the NMDAR effect in a continuously per-
fused recording chamber (Fig. 7G,H).
Physiological characterization of stem cell-derived
DA neurons traditionally includes generation of APs
by current injections in whole-cell current-clamp
recording [77,78]. However, due to massive release of
DA into the culture medium by DA neurons (Fig. 6)
and significant impact of DA on NMDAR functioning
(Fig. 7B), this approach may lead to biased character-
istics of observed APs. Therefore, suppression of DA
release and/or chelation of DA in extracellular solution
is needed to reproduce a physiological environment for
tested cells.
The concept of Gly and D-Ser as gliotransmitters,
the concentration of which in cerebrospinal fluid is to
a large extent regulated by astroglia, became popular
during last two decades [79,80]. The concept gives rise
to an obvious question as to what extent a given effect
is generated by D-Ser and/or Gly released from pri-
mary neurons vs. astroglia, which triggers long-lasting
emotional discussions [81,82]. Our experiments with D-
Ile demonstrated that primary neurons alone cannot
supply a sufficient amount of NMDAR coagonists for
regular AP generation (Fig. 7D,J,K). This suggests
astroglia to be if not a decisive, then, an important
factor maintaining NMDAR signalling in DA neu-
rons. Moreover, apart from release of coagonists into
the extracellular space (studied in our work), regula-
tory impact of astroglia could potentially be translated
through more indirect mechanisms, such as a ’serine
shuttle’ (regulation of L-serine/D-Ser balance) [63] or
modulation of synthesis of tissue plasminogen activa-
tor [83], which, in turn, enhances NMDAR signalling
[84]. On top of that, astroglia-released phosphatidic
acid was shown to promote dendrite branching in cell
culture, which enhances a number of NMDAR-con-
taining glutamatergic synapses and NMDAR expres-
sion [85].
Direct interaction of DA receptors’ ligands with
NMDAR was repeatedly reported for at least several
decades [50,57,86], but correspondent molecular action
mechanisms still remain to a large extent unknown.
Here, for the first time, we demonstrate that DA inter-
acts with the Gly binding site, but neither acts as an
open-channel blocker nor modulator of the Glu bind-
ing/dissociation. The lower effect of DA on positive
membrane potential (Fig. 8C,D) may suggest a volt-
age-dependent nature of its action mechanism. Our
observations are thus in line with an earlier report of
voltage-dependent DA action at NMDAR, which was
not changed under different Mg2+ concentrations [57].
However, such a complex nature of the DA effect
manifestation prevents an immediate conclusion about
its direct competitive interaction with Gly at
NMDAR; rather, it may be a result of remote modula-
tion of the Gly binding site.
The demand for neural grafts with minimum side
effects has led to the application of a great deal of
research efforts to find protocols that allow generation
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of uniform neuronal populations from stem cells
[87,88], in particular uniform populations of DA neu-
rons [89]. However, proper neurogenesis and differenti-
ation of neural cells require variable intercellular
crosstalk with managing signals coming from neurons
of different types [90,91] and from non-neuronal cells
such as endothelial cells and astroglia [92,93]. This
apparent discrepancy gives rise to a question as to
what extent hESC-derived uniform neural cell prepara-
tions reproduce properties of target neurons developed
in living tissue, in particular the pattern of interneu-
ronal crosstalk and signal modulation in a neural net-
work. To the best of our knowledge, until now there
has been no evidence of AP generation in response to
NMDAR-mediated interneuronal signalling in hESC-
derived DA cultures, which questions the development
of fundamental properties of neural networks such as
synaptic strength and synaptic plasticity [94,95]. The
absence of significant NMDAR input into AP genera-
tion observed in our first experiment on EPSPs (Fig. 2
C) was in agreement with this situation. It is widely
accepted that the number and strength of developing
excitatory synapses are promoted by excitatory synap-
tic activity, in which NMDARs play a major role
[85,96–98]. Hence, continuous silencing of NMDARs
in DA neural culture may lead to synaptic underdevel-
opment and poor excitatory transmission. This, how-
ever, was not observed in our study: the experiment on
AP generation displayed proper NMDAR-mediated
transmission (Fig. 7G), although immunostaining
revealed a significantly lower level of NMDAR–PSD-
95 colocalization than that for GABAAR–PSD-95
(Fig. 5). Furthermore, devoid of suppression by DA
and supplied with native concentrations of Gly and D-
Ser, excitatory synapses demonstrated adequate spon-
taneous NMDAR-mediated activity (Fig. 7I).
There are several possible explanations of these phe-
nomena. First, silencing of synaptic NMDARs increases
a number of excitatory synapses in the developing neu-
ral network [99]. Second, the intracellular C terminus of
NMDAR was shown to be sufficient for proper synaptic
formation and maturation independent of NMDAR
ionotropic activity and gating [100]. Altogether, these
factors may set a balance allowing normal synaptic
development in pure DA neuronal cultures.
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